The recent outbreaks of avian influenza (AI) worldwide have highlighted the difficulties in controlling this disease. Vaccination has become a recommended tool to support the eradication efforts and to limit the economic losses due to AI. A vaccination system based on the use of a vaccine containing a heterologous neuraminidase to the field virus has been shown to be efficacious in reducing the viral shedding and clinical symptoms and in differentiating vaccinated from infected animals (2). To further develop this so called differentiating infected from vaccinated animal vaccination system, two reassortant avian influenza viruses of the H7N5 subtype have been generated. The aim of this study was to generate a prototype strain with a rare N subtype to avoid interference with the anti-N discriminatory test.
How to translate text using browser tools
1 March 2007
Generation of Avian Influenza Reassortant Viruses of the H7N5 Subtype as Potential Vaccine Candidates to Be Used in the Framework of a “DIVA” Vaccination Strategy
Maria Serena Beato,
Michela Rigoni,
Adelaide Milani,
Ilaria Capua
ACCESS THE FULL ARTICLE
Avian Diseases
Vol. 51 • No. s1
March 2007
Vol. 51 • No. s1
March 2007
avian influenza
reassortant virus
vaccination